Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)
NCT01678300 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2015-11-16
Summary
The purpose of this protocol is:
1. To quantify the prevalence of adherence to topical mesalamine in patients with UC
2. To describe the determinants of medication adherence in patients with UC prescribed topical mesalamine
Conditions
Sponsors & Collaborators
-
Beth Israel Deaconess Medical Center
lead OTHER
Principal Investigators
-
Alan C Moss, MD · Beth Israel Deaconess Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2015-11-30
- Completion
- 2015-11-30
Countries
- United States
Study Locations
More Related Trials
-
Improving Knowledge of Medication in Ulcerative Colitis With an Iphone Application
NCT02120391 ·Status: COMPLETED ·Phase: NA
-
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
NCT01393405 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of HMPL-004 in Subjects With Crohn's Disease
NCT00655733 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis
NCT02330653 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study for the Treatment of Ulcerative Colitis With Adacolumn
NCT00102193 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
NCT00659802 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Outcome of Treatment of Ulcerative Colitis in Adult
NCT06143163 ·Status: NOT_YET_RECRUITING
-
Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis
NCT00767728 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease
NCT01847170 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)
NCT00300118 ·Status: COMPLETED ·Phase: PHASE3
-
Critical State of "Remission-Recurrence" of Ulcerative Colitis
NCT06694883 ·Status: RECRUITING
-
Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis
NCT02093663 ·Status: COMPLETED ·Phase: PHASE3
-
Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis
NCT00744016 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics
NCT06109441 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Responsiveness of Endoscopic Evaluation in UC
NCT01960439 ·Status: COMPLETED
-
Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative Colitis
NCT02442037 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
NCT00656890 ·Status: COMPLETED ·Phase: PHASE2
-
Faecal Microbiota Transplantation in Ulcerative Colitis
NCT01896635 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis
NCT05907330 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Treatment of UC
NCT06591013 ·Status: COMPLETED ·Phase: NA
-
Mediterranean Diet as an add-on Therapy for Induction of Remission in Patients With Active Crohn's Disease
NCT02825316 ·Status: UNKNOWN ·Phase: NA
-
Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)
NCT02620514 ·Status: COMPLETED ·Phase: NA
-
Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions
NCT02738125 ·Status: COMPLETED
-
Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis
NCT05743153 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Fecal Microbiota Transplantation as add-on Therapy in Mild-to-moderate Ulcerative Colitis
NCT05538026 ·Status: COMPLETED ·Phase: NA